Trial of New Dietary Treatment of Diabetes
NCT00128089 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2005-12-21
Summary
This is a preliminary trial of a new dietary approach to the treatment of obesity related type 2 diabetes.
Study terminated December 19, 2005 for administrative reasons.
Conditions
- Diabetes Mellitus, Type 2
Interventions
- BEHAVIORAL
-
Dietary treatment
Sponsors & Collaborators
-
Manassas Internal Medicine
lead OTHER
Principal Investigators
-
John F Cary, MD · Manassas Internal Medicine
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
- Completion
- 2005-12-31
Countries
- United States
Study Locations
More Related Trials
-
Liraglutide in Newly Onset Type 1 Diabetes.
NCT01879917 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
NCT01508923 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Strategies for Remission of Type 2 Diabetes
NCT04943926 ·Status: RECRUITING ·Phase: NA
-
Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus.
NCT02225951 ·Status: TERMINATED ·Phase: NA
-
Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
NCT02960659 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT01234649 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes
NCT03582956 ·Status: TERMINATED ·Phase: NA
-
Carbohydrates Under Target for Type 1 Diabetes Management
NCT04758858 ·Status: WITHDRAWN ·Phase: NA
-
52 Week Trial of Liraglutide in Type 1 Diabetes
NCT01787916 ·Status: COMPLETED ·Phase: PHASE4
-
Lean Diabetes Study
NCT05407831 ·Status: WITHDRAWN
-
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
NCT03195400 ·Status: COMPLETED
-
Study TO Prevent Diabetes With Short-term Insulin Glargine Only
NCT01276912 ·Status: UNKNOWN ·Phase: NA
-
A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes
NCT05297045 ·Status: TERMINATED ·Phase: PHASE2
-
Low Glycemic Index Diet in Patients With Type 1 Diabetes
NCT01184703 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes
NCT03449654 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of GLP-1 for Diabetic Bariatric Patients
NCT04624672 ·Status: TERMINATED ·Phase: PHASE4
-
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
NCT02443155 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes
NCT00544206 ·Status: COMPLETED ·Phase: PHASE2
-
Recombinant Human Leptin Therapy Effects on Insulin Action
NCT01207934 ·Status: COMPLETED ·Phase: NA
-
The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis
NCT02765399 ·Status: COMPLETED ·Phase: PHASE4
-
Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects
NCT03991299 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
NCT00445627 ·Status: COMPLETED
-
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
NCT02082496 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
NCT06503809 ·Status: RECRUITING ·Phase: NA
-
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
NCT01509742 ·Status: COMPLETED ·Phase: PHASE1